Physician profile
John A Varner
NPI 1770578338
$609.55
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $417 · 2020: $48.44 · 2021: $33.79 · 2024: $110.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $110.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $109.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $168.83 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $89.43 | 2019-2021 | |
| Medtronic Vascular, INC. | $70.36 | 2019 | |
| Janssen Pharmaceuticals, INC | $38.67 | 2019-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $36.98 | 2019-2020 | |
| Amgen INC. | $35.21 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $30.42 | 2024 | Verquvo |
| Regeneron Healthcare Solutions, INC. | $24.24 | 2019 | |
| Scpharmaceuticals INC. | $20.60 | 2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $18.59 | 2020 | |
| Lexicon Pharmaceuticals, INC. | $18.16 | 2024 | |
| Boston Scientific Corporation | $16.81 | 2021 | |
| Medtronic USA, INC. | $15.31 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $13.44 | 2024 | Eliquis |
| Boehringer Ingelheim Pharmaceuticals, INC. | $12.50 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Varner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.